top of page
  • Writer's pictureagbiopro

UK Immune Cell Therapy Biotech Founded with €40M Series A

Updated: Jun 7, 2019

Quell Therapeutics, a London-based biotech developing immune cell therapies to target transplant rejection and autoimmune and inflammatory diseases.


12 views0 comments

Comments


bottom of page